Restless Legs Syndrome
📧 Sign up to get email alerts when something new happens for Restless Legs Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-10-31Clinical Trial Update: Pramipexole (BI-Sifrol®) Orally Once Daily for 6 Weeks in Patients With Primary Restless Legs Syndrome [Phase 2]
Phase 2 trial evaluating once-daily pramipexole (BI-Sifrol) for 6 weeks in patients with Restless Legs Syndrome; the study status is complet…
-
CLINICAL_TRIALS trial_result · 2013-10-31Clinical Trial Update: A 6 Week Trial to Study the Efficacy and Safety of a Starting Dose 0.25 mg Pramipexole (Mirapex) in Patients With RLS [Phase 4]
This clinical trial update reports a Phase 4 study evaluating the efficacy and safety of starting dose 0.25 mg pramipexole (Mirapex) in pati…
-
FDA approval · 2013-10-29FDA Approved: HORIZANT — Supplemental Application (Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals))
The FDA approved a supplemental application for Horizant (gabapentin enacarbil) from Azurity Pharmaceuticals (formerly Arbor Pharmaceuticals…
-
CLINICAL_TRIALS trial_result · 2013-10-22Clinical Trial Update: Restless Legs Syndrome in Stroke Patients
This update reports the completion of a clinical trial investigating restless legs syndrome in patients who have experienced a stroke (inclu…
-
CLINICAL_TRIALS research · 2013-10-01Clinical Trial Update: Validation Study for an Unobtrusive Online Sleep Measurement System
This document reports the completion of a validation study evaluating an unobtrusive online sleep measurement system.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2013-08-15Clinical Trial Update: Comprehensive Police Fatigue Management Program [NA]
Clinical trial update showing the Comprehensive Police Fatigue Management Program trial, sponsored by Brigham and Women's Hospital, has comp…
-
FDA approval · 2013-07-31FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for pramipexole dihydrochloride from Macleods Pharmaceuticals Limited. This action updates the p…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: Effects of Neupro on Cardiovascular Observations in Patients With Restless Legs Syndrome [Phase 4]
Phase 4 trial evaluating cardiovascular effects of Neupro (rotigotine) in patients with Restless Legs Syndrome; results have been posted.
-
CLINICAL_TRIALS trial_result · 2013-07-16Clinical Trial Update: Study to Assess the Effect of Gabapentin Enacarbil on Simulated Driving in Healthy Subjects [Phase 1]
Phase 1 study update evaluating the effect of gabapentin enacarbil on simulated driving in healthy subjects, with restless legs syndrome as …
-
CLINICAL_TRIALS trial_result · 2013-07-16Clinical Trial Update: Drug Drug Interaction Study With Gabapentin Enacarbil and Morphine [Phase 1]
A Phase 1 study evaluated potential drug-drug interaction between gabapentin enacarbil and morphine in Restless Legs Syndrome; the trial has…
-
CLINICAL_TRIALS trial_result · 2013-05-14Clinical Trial Update: XP13512 (GSK1838262) Versus Placebo in Patients With Restless Legs Syndrome. [Phase 3]
Phase 3 trial comparing XP13512 (GSK1838262) to placebo in patients with Restless Legs Syndrome has completed.
-
FDA approval · 2013-05-01FDA Approved: HORIZANT — Supplemental Application (Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals))
FDA approved a supplemental application for Horizant (gabapentin enacarbil) by Azurity Pharmaceuticals, Inc.
-
FDA approval · 2013-04-22FDA Approved: ROPINIROLE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's original application for a generic ropinirole product.
-
FDA approval · 2013-03-27FDA Approved: HORIZANT — Supplemental Application (Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals))
FDA approved a supplemental application for HORIZANT (gabapentin enacarbil) submitted by Azurity Pharmaceuticals, Inc. (formerly Arbor Pharm…
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Safety and Efficacy of Rasagiline in Restless Legs Syndrome [Phase 2, Phase 3]
A terminated Phase 2/Phase 3 trial evaluated the safety and efficacy of rasagiline in patients with restless legs syndrome.
-
FDA approval · 2012-12-26FDA Approved: HORIZANT — Supplemental Application (Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals))
FDA approved a supplemental application for Horizant (gabapentin enacarbil) submitted by Azurity Pharmaceuticals (formerly Arbor Pharmaceuti…
-
FDA approval · 2012-11-28FDA Approved: ROPINIROLE — Original Application (Bionpharma Inc.)
FDA approved the original application for ropinirole from Bionpharma Inc., representing a generic version of ropinirole. This marks the avai…
-
FDA approval · 2012-10-31FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for pramipexole dihydrochloride from Torrent Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2012-10-26Clinical Trial Update: Bioequivalence Study of Ropinirole Hydrochloride CR 2mg Tablets of Lupin Limited, India, With REQUIP XL of GlaxoSmithKline Research Triangle Park, in Healthy, Adult, Male, Subjects Under Fed Conditions [Phase 1]
A Phase 1 bioequivalence study comparing Lupin's ropinirole hydrochloride CR 2 mg tablets to GlaxoSmithKline's REQUIP XL under fed condition…
-
FDA approval · 2012-10-26FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for Pramipexole dihydrochloride as a generic product, manufactured by Aurobindo Pharma Limited, for th…
-
CLINICAL_TRIALS trial_result · 2012-10-08Clinical Trial Update: Polysomnography Study Of Pregabalin And Pramipexole Versus Placebo In Patients With Restless Legs Syndrome And Associated Sleep Disturbance [Phase 3]
Phase 3 trial comparing pregabalin and pramipexole against placebo for restless legs syndrome with sleep disturbance; completed with results…
-
CLINICAL_TRIALS trial_result · 2012-09-28Clinical Trial Update: Non-interventional Study (NIS) in Patients With Restless Legs Syndrome in Daily Practise
A non-interventional study assessing patients with restless legs syndrome in routine practice has completed, with results posted in 2012.
-
FDA approval · 2012-09-20FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original application for pramipexole dihydrochloride from Macleods Pharmaceuticals Limited, marking the entry of a generic …
-
CLINICAL_TRIALS trial_result · 2012-09-11Clinical Trial Update: Safety and Effect of Mirapex(Pramipexole) Tablet Among Korean RLS
This completed clinical trial in Korean participants evaluated the safety and effect of Mirapex (pramipexole) tablets for Restless Legs Synd…
-
CLINICAL_TRIALS research · 2012-08-14Clinical Trial Update: Suggested Immobilization Test (SIT) Test for Early Detection of Restless Legs Syndrome (RLS) Augmentation - Proof of Concept
A completed proof-of-concept clinical trial evaluating a suggested immobilization test for early detection of augmentation in restless legs …